Clinical Trial Update: Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating anesthetic agents and acute kidney injury after liver resection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Neoplasms
• Hepatocellular Carcinoma
• Hepatoma

Snippet

Sponsor: Tokyo Medical and Dental University | Conditions: Hepatocellular Carcinoma, Hepatoma | Phase 4 | Status: WITHDRAWN